2019
Drug Portfolio Analysis
© Copyright Ingenious e-Brain Solutions | All Rights Reserved
2
1. OVERVIREW The objective of drug portfolio study was to analyze the pattern and compare portfolio of drugs in pipeline to those being translated to FDA approval stage. Key drivers and challenges were also identified with respect to drugs in various therapeutic domains along with unmet medical needs. Issues and Concerns: • •
Fewer FDA Approvals Blockbusters v/s Targeted Therapeutics
• •
Drug Safety Political Landscape
For More Details @ https://www.iebrain.com/post/technology-landscape-of-drug-portfolioanalysis/
3
About us: We are a globally recognized research and analytics solutions provider with a team of experienced professionals from diverse technical domains. Our services, ranging from technology ideation to commercialization, are tailored to help our clients transform their business model by providing them holistic solutions around Intellectual Property, Technology, and Business Intelligence. Our clients include R&D groups, attorneys, and inventors from large law firms and Fortune 500 companies. Phone [US]: +1 347 480 2054 Phone [UK]: +44 207 193 3548 Email: services@iebrain.com For Industry Services : https://www.iebrain.com/pharmaceuticals-industry-service/